–
Boulogne-Billancourt, May 18, 2021 – Each year, nearly 1.75 million new cases and nearly 400,000 deaths are linked to complications from infection with the hepatitis C virus. In France, it is estimated that 90,000 patients remain to be detected and treat, while 90,000 have been cured since 2014. The elimination of viral hepatitis in 2030 was announced by the World Health Organization as a global public health issue. France for its part has deployed a national strategy for the elimination of HCV by 2025.
As a major player in therapeutic innovation in this disease and having identified a need for additional information from general practitioners, Gilead France has developed a website dedicated to them, summarizing all the data they may need on the disease. disease, its prevention, its screening … The aim of this educational tool is to facilitate the information of health professionals, but also to improve their exchanges with their patients, and thus help to promote actions of prevention and screening of the Hepatitis C.
With this website www.eliminonslhepatitec.fr, health professionals will be able to download technical sheets. Numerous infographics make it possible to understand at a glance the key epidemiological figures, the characteristics of the virus, the populations at risk, etc. Infographics that they can share during the consultation with their patient.
The site is divided into several sequences, some accessible to all:
- Learn about HCV: This page explains the hepatitis C virus, how the disease affects the patient, and how it is transmitted.
- Screening for HCV: This page explains which populations are most at risk of having been infected with the virus, the screening methods available, and gives indicators for interpreting the results.
- Eliminate HCV: This page provides an update on the hepatitis C elimination objectives in the world and in France.
Two parts are reserved for healthcare professionals, those concerning information on care and practical tools.
–
–
